Literature DB >> 15106244

Psychological interventions for women with metastatic breast cancer.

A G K Edwards1, S Hailey, M Maxwell.   

Abstract

BACKGROUND: There have been conflicting results from systematic reviews of psychological interventions for patients with cancer, some showing benefits for patients and others not. One early study appeared to show significant survival benefits as well as psychological benefits from a psychological intervention given to women with metastatic breast cancer. Some further studies have been undertaken, again with conflicting results.
OBJECTIVES: To assess the effects of psychological interventions (educational, individual cognitive behavioural or psychotherapeutic, or group support) on psychological and survival outcomes for women with metastatic breast cancer. SEARCH STRATEGY: We searched the Cochrane Breast Cancer Group Trials Register (September 2003), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 4, 2003), MEDLINE (1966-October 2003), CancerLit (1983-2000), CINAHL (1982-October 2003), PsycInfo (1974-November 2003), and SIGLE (1980-November 2003). SELECTION CRITERIA: Randomised controlled trials (RCTs) of psychological interventions for women with metastatic breast cancer. Studies were included even if they were not 'intention to treat', owing to the nature of the patient group under study and the likely high loss of follow-up data. DATA COLLECTION AND ANALYSIS: Data were extracted independently by two reviewers. Data about the nature and setting of the intervention, and the relevant outcome data were extracted, along with items relating to methodological quality. MAIN
RESULTS: Five primary studies were identified, all group psychological interventions. Two of these were cognitive behavioural interventions and three evaluated support-expressive group therapy. The five studies of group psychological therapies for women with metastatic breast cancer showed very limited evidence of benefit arising from these interventions. Although there was evidence of short-term benefit for some psychological outcomes, in general these were not sustained at follow-up. A clearer pattern of psychological outcomes could not be discerned as a wide variety of outcome measures and durations of follow-up were used in the included studies. The possible longer survival times in women allocated to receive psychological intervention in the early study have not been replicated in the subsequent four studies (including one by members of the first study group), and overall the effects of these interventions on survival are not statistically significant (for example, odds ratio for 5 year survival 0.83 (95% confidence interval [CI] 0.53 - 1.28). REVIEWERS'
CONCLUSIONS: There is insufficient evidence to advocate that group psychological therapies (either cognitive behavioural or supportive-expressive) should be made available to all women diagnosed with metastatic breast cancer. Any benefits of the interventions are only evident for some of the psychological outcomes and in the short term. The possibility of the interventions causing harm is not ruled out by the available data.

Entities:  

Mesh:

Year:  2004        PMID: 15106244     DOI: 10.1002/14651858.CD004253.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  11 in total

1.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

Review 2.  Impact of cancer on everyday life: a systematic appraisal of the research evidence.

Authors:  Ikumi Okamoto; David Wright; Claire Foster
Journal:  Health Expect       Date:  2011-02-18       Impact factor: 3.377

3.  Effects of exercise intervention on persons with metastatic cancer: a systematic review.

Authors:  Rebekah Beaton; Wendy Pagdin-Friesen; Christa Robertson; Cathy Vigar; Heather Watson; Susan R Harris
Journal:  Physiother Can       Date:  2009-07-16       Impact factor: 1.037

4.  Evaluation of two group therapies to reduce fear of progression in cancer patients.

Authors:  Peter Herschbach; Katrin Book; Andreas Dinkel; Petra Berg; Sabine Waadt; Gabriele Duran; Ursula Engst-Hastreiter; Gerhard Henrich
Journal:  Support Care Cancer       Date:  2009-10-29       Impact factor: 3.603

5.  A cognitive-existential intervention to improve existential and global quality of life in cancer patients: A pilot study.

Authors:  Pierre Gagnon; Lise Fillion; Marie-Anik Robitaille; Michèle Girard; François Tardif; Jean-Philippe Cochrane; Joanie Le Moignan Moreau; William Breitbart
Journal:  Palliat Support Care       Date:  2014-07-22

6.  Unmet needs in cancer patients: development of a supportive needs screening tool (SNST).

Authors:  Cathie Pigott; Annabel Pollard; Kathryn Thomson; Sanchia Aranda
Journal:  Support Care Cancer       Date:  2008-05-16       Impact factor: 3.603

Review 7.  Psychosocial interventions for reducing fatigue during cancer treatment in adults.

Authors:  Martine Margaretha Goedendorp; Marieke F M Gielissen; Constantijn A H H V M Verhagen; Gijs Bleijenberg
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

8.  Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial.

Authors:  S Aranda; P Schofield; L Weih; D Milne; P Yates; R Faulkner
Journal:  Br J Cancer       Date:  2006-09-18       Impact factor: 7.640

Review 9.  Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients.

Authors:  Karen Galway; Amanda Black; Marie Cantwell; Chris R Cardwell; Moyra Mills; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 10.  Complementary and alternative medicine for cancer pain: an overview of systematic reviews.

Authors:  Yanju Bao; Xiangying Kong; Liping Yang; Rui Liu; Zhan Shi; Weidong Li; Baojin Hua; Wei Hou
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.